Home » Abbvie Earnings Beat Estimates as Botox Shows Signs of Revival

Abbvie Earnings Beat Estimates as Botox Shows Signs of Revival

July 31, 2026July 31, 2026

Abbvie Earnings Beat Estimates as Botox Shows Signs of Revival

This post was originally published on this site.

Abbvie reported second quarter profit and sales that topped expectations, driven by strong demand across its immunology and neuroscience franchises and further signs of a recovery in Botox.

FlashNews:

Mahrajan Festival is a ‘milestone’ for Arabic community

AI Slop Melodramas Are Taking Over X—and Their Creators Are Cashing In

Yeezy Has Officially Re-Entered the Zeitgeist

Nigeria date removed from South African pop star Tyla’s world tour after boycott petition

This AI Assistant Wants to Make Up for Your Boyfriend’s Incompetence

Pinnacle Crypto Exchange Completes Review and Ecosystem Data Disclosure

Spanish prime minister condemns influx of 60,000 migrants

ECB says digital euro app will exceed EU accessibility standards

Black Tie CBD Expands Indoor and Exotic THCA Flower Collection with New Strains, $5 Add-On Offer and 30-Day Guarantee

A bitter pill: are you wasting your money on supplements?

AMLBot launches AI Tracer for self-service blockchain investigations

Here comes the alt-bride: wedding gowns enter a more experimental era

Markets are getting AI right

Nancy Fulton Walker Announces the Release of My Soul Sings of Scotland, A Collection of Poetry and Photography

Abbvie Earnings Beat Estimates as Botox Shows Signs of Revival

New Novel Explores a Young Woman’s Journey Behind Convent Walls in 1960s America

Seascanner to offer exclusive ‘Rock vs Country’ entertainment onboard MSC

Matthias Spohr appointed Chief Operating Officer of Eurowings

eSUN Unveils Application-Specific PLA Filament Portfolio to Streamline 3D Printing Workflows

BANA Accelerates Global RWA Financial Ecosystem Expansion with Strategic Focus on the Middle East and Europe

Abbvie Earnings Beat Estimates as Botox Shows Signs of Revival